Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS).
Pediatr Rheumatol Online J
; 21(1): 38, 2023 Apr 22.
Article
in En
| MEDLINE
| ID: mdl-37087470
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Interferon Type I
/
Hereditary Autoinflammatory Diseases
/
Janus Kinase Inhibitors
/
East Asian People
Type of study:
Clinical_trials
Limits:
Adult
/
Child
/
Female
/
Humans
/
Male
Language:
En
Journal:
Pediatr Rheumatol Online J
Year:
2023
Document type:
Article
Affiliation country:
Japan
Country of publication:
United kingdom